Irritable Bowel Syndrome Trial, Recruiting NCT06413004 Sponsor: Magnus Simrén Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT06413004
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Irritable Bowel Syndrome (IBS) by your doctor, using a standard set of diagnostic guidelines.
  • You notice that eating food triggers your gut or digestive symptoms.
  • You are able and willing to sign a consent form before any study activities begin.
  • You are able to understand the study and its questionnaires, and can follow the study requirements throughout.

Who may not be able to join:

  • You have a significant ongoing gut disease (such as inflammatory bowel disease or abdominal cancer), or a serious condition such as diabetes, uncontrolled thyroid disease, heart disease, kidney disease, liver disease, or an active cancer (though a cancer that has been in full remission for at least 5 years may be acceptable — confirm with trial site).
  • You have had bowel surgery in the past that affects how your gut moves food through (not including appendix or gallbladder removal).
  • You have a whole-body food allergy confirmed by a blood test or skin prick test.
  • You have a history of severe allergic reactions.
  • You have a significant mental health condition, severe depression, or have had problems with alcohol or substance misuse in the last 2 years (confirm with trial site).
  • You are currently pregnant or breastfeeding; women of childbearing age are asked to use reliable contraception during the study.
  • You have started or recently changed medications that affect your digestive system within the last month before the study begins.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0046313428107

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Magnus Simrén
Registry
ClinicalTrials.gov
Start date
3 August 2022
Est. completion
1 December 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

IBS-SSS (Irritable Bowel Syndrom Severity Scoring System) after exclusion (proportion).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov